Position in CTMX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$7,513,693
+$652,451 QoQ
Shares Held
2,003,652
+37.3% QoQ
Ownership
0.920%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#23
of 178 holders
Holding Since
Mar 2020
23 quarters on record
Voting authority
Sole 99%
Shared 1%
None 0%
Common Shares in CTMX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026GOLDMAN SACHS GROUP INC holds $13,040,380,016 across 360 Biotechnology names. CTMX ranks #171 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,481,761 | $1,232,765,138 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,163,191 | $725,296,113 | |
| 3 | ROIV |
Roivant Sciences Ltd.
|
18,556,458 | $656,713,046 | |
| 4 | TECH |
BIO-TECHNE Corp
|
7,343,324 | $518,805,838 | |
| 5 | RVMD |
Revolution Medicines, Inc.
|
2,133,101 | $399,487,154 | |
| 6 | MRNA |
Moderna, Inc.
|
4,671,950 | $327,176,656 | |
| 7 | TNGX |
Tango Therapeutics, Inc.
|
9,980,620 | $311,994,180 | |
| 8 | INCY |
Incyte Corp
|
2,305,782 | $261,383,446 |
All Filings in CTMX
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $7,513,693 | 2,003,652 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $6,861,242 | 1,459,839 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $10,483,620 | 2,460,944 | Shares | Defined | 2026-03-25 | |
| 2025-09-30 | $1,428,331 | 447,753 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $33,319 | 14,678 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $39,253 | 61,719 | Shares | Defined | 2025-06-27 | |
| 2024-09-30 | $14,160 | 12,000 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $133,348 | 109,302 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $640,688 | 293,894 | Shares | Defined | 2024-05-15 | |
| 2023-06-30 | $17,573 | 10,217 | Shares | Defined | 2024-05-14 | |
| 2023-03-31 | $20,229 | 13,397 | Shares | Defined | 2024-05-14 | |
| 2022-12-31 | $166,277 | 103,924 | Shares | Defined | 2024-05-14 | |
| 2022-09-30 | $193,854 | 133,693 | Shares | Defined | 2024-05-14 | |
| 2022-06-30 | $343,201 | 187,542 | Shares | Defined | 2024-05-14 | |
| 2022-03-31 | $2,025,432 | 758,589 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $2,757,975 | 636,946 | Shares | Defined | 2022-02-17 | |
| 2021-09-30 | $5,645,140 | 1,109,065 | Shares | Defined | 2022-01-20 | |
| 2021-06-30 | $6,026,267 | 952,017 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $1,616,358 | 209,102 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $1,489,790 | 227,449 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $1,860,822 | 279,823 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $2,314,448 | 277,845 | Shares | Defined | 2020-08-12 | |
| 2020-03-31 | $1,058,828 | 138,048 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||